

Novel vaccines for chronic disease treatment and prevention
Cytos Biotechnology is dedicated to the discovery, development and commercialization
of a novel class of medicines – called Immunodrugs™. Immunodrugs™ are therapeutic
vaccines intended for use in the treatment and prevention of common chronic diseases
which afflict millions of people worldwide.
2010, July 22:
Cytos' second quarter report.
2010, July 15:
A*STAR & Cytos Biotechnology establish influenza vaccine collaboration.
2010, July 5:
Matter Group AG holds 3.4155% of share capital.